Research has demonstrated that TREX1 deficiency has a close association with various autoimmune diseases (e.g., AGS, SLE) and that in TREX1-deficient mouse models, deletion of cGAS or STING can ameliorate these disease phenotypes (79–81). This evidence concerns the gene TREX1 and Aicardi-Goutieres syndrome.